The genome of eukaryotic cells is frequently exposed to damage by various genotoxins. Phosphorylation of histone H2AX at Serine 139 (c-H2AX) is a hallmark of DNA damage. RNF8 monoubiquitinates c-H2AX with the Lys63-linked ubiquitin chain to tether DNA repair molecules at DNA lesions. A high-throughput screening identified RNF8 as a binding partner of dualspecificity tyrosine phosphorylation-regulated kinase 2 (DYRK2). Notably, DNA damage-induced monoubiquitination of c-H2AX is impaired in DYRK2-depleted cells. The foci formation of p53-binding protein 1 at DNA double-strand break sites is suppressed in DYRK2 knockdown cells, which fail to repair the DNA damage. A homologous recombination assay showed decreased repair efficiency in DYRK2-depleted cells. Our findings indicate direct interaction of DYRK2 with RNF8 in regulating response to DNA damage.
The genome of eukaryotic cells is frequently exposed to damage by various genotoxins. Phosphorylation of histone H2AX at Serine 139 (c-H2AX) is a hallmark of DNA damage. RNF8 monoubiquitinates c-H2AX with the Lys63-linked ubiquitin chain to tether DNA repair molecules at DNA lesions. A high-throughput screening identified RNF8 as a binding partner of dualspecificity tyrosine phosphorylation-regulated kinase 2 (DYRK2). Notably, DNA damage-induced monoubiquitination of c-H2AX is impaired in DYRK2-depleted cells. The foci formation of p53-binding protein 1 at DNA double-strand break sites is suppressed in DYRK2 knockdown cells, which fail to repair the DNA damage. A homologous recombination assay showed decreased repair efficiency in DYRK2-depleted cells. Our findings indicate direct interaction of DYRK2 with RNF8 in regulating response to DNA damage.
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lesions. RNF8 contains an N-terminal forkhead-associated (FHA) domain and a C-terminal RING-finger domain responsible for its ubiquitin ligase activity [3] . FHA domains recognize exclusively phospho-threonine (pThr)-containing motifs, compared to BRCA1 carboxyl terminus (BRCT) domains that recognize both phospho-serine-(pSer) and pThr-containing sequences. Accordingly, RNF8 specifically binds to Thr-phosphorylated substrates [4] . RNF8 recognizes three pTQXF motifs in MDC1 [5] . Together with the E2-conjugating enzyme UBC13, RNF8 catalyzes histone H2AX Lys 63-linked ubiquitination in response to DSBs. Ubiquitinated histone H2AX tethers DNA repair factors including RNF8, p53-binding protein 1 (53BP1), and BRCA1 to the DSB sites, thereby initiating homologous recombination (HR) [6] .
Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) is a Ser/Thr kinase that regulates cell cycle progression, cell migration, and apoptosis. DYRK2-depleted cancer cells exhibit aberrant cell growth and metastasis [7, 8] . Immunohistochemical analysis indicated significant reduction in DYRK2 expression in invasive breast tumor tissues. Resistance of ovarian cancer cells to cisplatin is associated with reduced DYRK2 expression, indicating its tumor-suppressive role [9] . In response to genotoxic stress, DYRK2 phosphorylates p53 at Ser46 [10] . Ser46 phosphorylation is detected in the later stages of genotoxic stimuli-induced signaling, and it contributes to the induction of cell death [11, 12] . In a genome-wide shRNA screening aimed at identifying the molecules involved in DNA repair, DYRK2 was ranked among the top 38 candidates [13] . However, it remains unclear whether DYRK2 physiologically affects DNA repair.
Here, we demonstrated that DYRK2 regulated the ubiquitination activity of RNF8 through direct interaction. Depletion of DYRK2 impaired 53BP1 foci formation at DSB sites, and down-regulated the repair efficiency, resulting in unsuccessful repair of DNA lesions.
Materials and methods

Screening for E3 ubiquitin ligases that interact with DYRK2
E3 ligase screening and cell-free synthesized E3 ubiquitin ligase protein array used in the present study were as described previously [14] . Briefly, FLAG-DYRK2 and FLAG-dihydrofolate reductase (DHFR) were synthesized using wheat cell-free protein synthesis system [15, 16] . E3 ligase protein array containing 223 N-terminal biotinylated E3 ligases was established using the mammalian gene collection (MGC) cDNA clone set [17] and functional annotation of mouse (FANTOM) cDNA clone set [18] . Biotinylated E3 ligases were synthesized using wheat germ cell-free synthesis system. Biotinylation of the biotin ligation site was accomplished using enzymatic biotinylation with BirA biotin ligase [19] 
Plasmids
Flag-tagged DYRK2 and GFP-tagged DYRK2 K178R mutant were cloned as previously described [10] . RNF8 cDNA was amplified by PCR and cloned into the pEGFP-C1 vector. Site-directed mutagenesis was performed using PCR and verified by DNA sequencing. The GFP-tagged RNF8 C403S mutant plasmid (gifted by S. Nakada, Osaka University) was cloned into the mCherry vector.
Cell Transfection
The RNF8-specific siRNA, DYRK2-specific siRNA, and control siRNA were purchased from Qiagen, Sigma, and Invitrogen, respectively. Transfections of validated gene-specific siRNAs were performed using Lipofectamine RNAi MAX (Invitrogen, Carlsbad, CA, USA) according to the supplied protocol. Flag-tagged DYRK2 and GFP-tagged RNF8 plasmids were transfected using FuGENE HD. The GFP-tagged DYRK2 K178R mutant and the mCherry-tagged RNF8 C403S mutant were transfected using X-tremeGENE9
(Roche, Basel, Switzerland) following the manufacturer's protocol.
Immunoprecipitation
293T cells were harvested, washed in phosphate-buffed saline (PBS), and resuspended in lysis buffer (50 mM TrisHCl, pH 7.6, 150 mM NaCl, 10 mM NaF, 1 mM Na 3 VO 4 , 1 mM PMSF, 1 mM DTT, 10 lgÁmL À1 aprotinin, 1 lgÁmL À1 leupeptin, 1 lgÁmL À1 pepstatin A, and 1% NP-40). After centrifugation, supernatants were isolated and used as cell lysates. For immunoprecipitation, lysates were incubated with anti-Flag-agarose (Sigma-Aldrich) for 2 h at 4°C. The immunoprecipitates were washed three times with lysis buffer. The bound proteins were eluted with SDS sample buffer and boiled for 5 min.
Immunoblotting
293T cells and U2OS cells were washed with PBS three times and then incubated with 10% trichloroacetic acid for 5 min. Cells were lifted and suspended in SDS sample buffer. Lysates were sonicated on ice. Cell extracts were separated by SDS/ PAGE and transferred on nitrocellulose membranes. The membranes were probed with anti-cH2AX (Millipore, Darmstadt, Germany), anti-H2AX (Cell Signaling Technology, Washington, DC, USA), anti-DYRK2 (Human Protein Atlas, Bromma, Sweden), anti-RNF8 (Santa Cruz Biotechnology, Dallas, TX, USA), anti-phospho-p53 (Ser46) (Bio Academia, Osaka, Japan), anti-p53 (Santa Cruz Biotechnology), anti-GST (Nacalai Tesque, Kyoto, Japan), anti-Tubulin (Sigma), anti-GAPDH (Chemicon, Darmstadt, Germany), anti-Flag (Cell Signaling Technology), or anti-GFP (Nacalai Tesque). Immune complexes were incubated with secondary antibodies and visualized using western lightning chemiluminescence reagent (PerkinElmer Life Sciences).
In vitro kinase assay
Recombinant His-DYRK2 protein was obtained from Merck. Recombinant GST-p53 was used as a substrate from the previous study [10] . His-DYRK2 was incubated in the kinase buffer (20 mM HEPES; pH 7.0, 10 mM MgCl 2 , 10 mM MnCl 2 , 0.1 mM Na 3 VO 4 , and 2 mM dithiothreitol) with GSTp53 and/or Harmine along with ATP for 5 min at 30°C. Reaction products were subjected to immunoblot analysis.
Comet assay
The alkaline comet assay was performed as described by Benjamin et al. [20, 21] . U2OS cells treated in the presence or absence of ADR or DYRK2 siRNA or Hydrogen peroxide (H 2 O 2 ) were combined with molten LM Agarose (Trevigen, Gaithersburg, MD, USA) at 37°C with a ratio of 1 : 10 (v/v), and immediately spread onto CometSlide (Trevigen). After 10 min of gelling at 4°C, the cells were lysed with lysis solution (Trevigen) at 4°C for 1 h. The slides were placed in a horizontal electrophoresis tank containing electrophoresis solution (200 mM NaOH, and 1 mM EDTA; pH > 13) and electrophoresis was ran for 30 min (21 V/cm). After electrophoresis, the slides were washed in distilled water for two times and immersed in 70% ethanol for 5 min and dried at 37°C for 10-15 min, and then stained with SYBR Gold Staining solution for 30 min. After staining, the slides were washed in distilled water and dried at 37°C for 30 min. Comet images were captured using a Zeiss Axioplan fluorescent microscope. The images were analyzed using OPENCOMET software and COMETSCORE version 1.5 software [20] . The extent of DNA damage was expressed as a measure of percentage of DNA in tail.
Immunofluorescence assay
The U2OS cells were seeded and cultured in the presence or absence of ADR or irradiation (2 Gy). Cells were permeabilized using 0.5% Triton X-100 in PBS for 15 mutant. After irradiation (10 Gy), cells were observed by using a fluorescence microscope (Biozero-8000; Keyence) equipped with a Plan Apochromat 20 9 /0.75 NA objective lens and (Nikon).
DNA damage
U2OS cells were exposed to X-rays using a Model MBR-1520R-3 irradiator (HITACHI, Tokyo, Japan).
Homologous recombination assay
U2OS cell carrying the DR (direct repeat)-GFP homologous recombination reporter was used for the analysis of HR. For analyses with siRNA, cells were transfected with control siRNA or DYRK2 siRNA and cultured in 6-cm dishes for 48 h. After the medium was changed, the cells were then transfected with 3.0 lg (DR-GFP assay) of pCBASceI (the I-SceI expression plasmid) using Xtreme-GENE9 (Roche). Cells were collected 48 h post plasmid transfection via trypsinization, washed twice with PBS, suspended in 0.1% FBS/PBS, and fixed with formaldehyde. The proportion of GFP-positive cells was determined using flow cytometry using a MACSQuant analyzer 10 (Miltenyi Biotec, Cologne, Germany).
Cell cycle analysis
U2OS cells carrying the DR (direct repeat)-GFP homologous recombination reporter were washed with chilled PBS and resuspended with PBS. After washing, cells were fixed with 70% ethanol and incubated with RNase and 7-AAD (7-Aminoactinomycin D) for 30 min at 37°C. Data from the flow cytometry were acquired and analyzed using a MACSQuant analyzer 10 (Miltenyi Biotec).
Statistics
Statistical analysis was performed using Student's t-test. Data represent the mean AE SD. P < 0.05 was considered as statistically significant.
Results
RNF8 is a novel-binding protein of DYRK2
Along with E3 ubiquitin ligases, DYRK2 promotes proteasome degradation of c-Jun, c-Myc, Snail, TERT, and Katanin p60 [22] . DYRK2 functions as a scaffold protein in the EDD-DDB1-VprBP (EDVP) E3 ligase complex associated with the degradation of TERT and Katanin p60 [23, 24] . To further define the characteristics of DYRK2, we screened for DYRK2-interacting E3 ubiquitin ligase(s) using a protein array generated by the wheat germ cell-free protein synthesis system. The screening process identified, four E3 ubiquitin ligases as potential in vitro binding proteins of DYRK2 (Fig. 1A) . Notably, in this screening, murine double minute 2 (MDM2) was screened out with the highest score. In our previous study, we demonstrated that DYRK2 is ubiquitinated by MDM2 under unstressed conditions [25] , suggesting the identification of physiologically interacting proteins of DYRK2 by this screening process. Subsequently, we examined the interaction of DYRK2 with RNF8 in cells, which was identified as one of the promising candidates in the screening process. To confirm the screening results, 293T cells were cotransfected with GFP-vector or GFP-tagged RNF8 and Flag-vector or Flag-tagged DYRK2 (Fig. 1B) . Ectopically expressed RNF8 interacted with DYRK2 in 293T cells. However, we could not detect endogeneous interaction between DYRK2 and RNF8 due to an unavailability of antibodies immunoprecipitating endogeneous DYRK2 or RNF8. Given that RNF8 is an E3 ubiquitin ligase, we hypothesized that RNF8 down-regulated DYRK2 expression by ubiquitination. However, the expression of DYRK2 remained unchanged in RNF8 knockdown cells (Fig. 1C) . These results demonstrated that RNF8 interacted with DYRK2 in the cells, but it was not involved in the degradation of DYRK2, indicating the possible regulation of RNF8 function by DYRK2.
DYRK2 is essential for the monoubiquitination of c-H2AX in response to genotoxic stress
Accumulating studies have shown the involvement of RNF8-mediated monoubiquitination of Histone H2A in the recruitment of DNA repair proteins at DSBs. In response to DNA damage, ATM protein kinase is activated and phosphorylates histone H2AX, a variant of histone H2A, at Ser139. ATM also phosphorylates MDC1. RNF8 binds to phosphorylated MDC1 and ubiquitinates ATM-phosphorylated H2AX (c-H2AX) [26] . Ubiquitinated c-H2AX promotes the recruitment of BRCA1 and 53BP1 at DSB sites. To evaluate the activity of RNF8 upon DNA damage, we monitored the level of endogenous c-H2AX monoubiquitination in response to genotoxic stress ( Fig. 2A) . As expected, c-H2AX was monoubiquitinated in the early phase after DNA damage. To examine the role of DYRK2 in the RNF8-mediated monoubiquitination of c-H2AX, U2OS cells were transfected with control siRNA or DYRK2-specific siRNA followed by ADR treatment, which triggered DSBs (Fig. 2B) . Monoubiquitination of c-H2AX was observed after an hour of DNA damage in U2OS cells transfected with control siRNA. However, knocking down DYRK2 attenuated c-H2AX monoubiquitination. Also, we confirmed that c-H2AX monoubiquitination was not detected in the RNF8 knocking down cells (Fig. 2B) . To exclude the possibility of association of knocking down DYRK2 with off-target effects, two DYRK2 siRNAs that target different sequences of DYRK2 were transfected into U2OS cells followed by ADR treatment (Fig. S1A ). Both the siRNAs attenuated c-H2AX monoubiquitination in response to DNA damage, suggesting an essential role of DYRK2 in the monoubiquitination of c-H2AX by RNF8 following genotoxic stress. Moreover, we quantified c-H2AX monoubiquitination level in ADR-treated control and DYRK2 knockdown cells (Fig. S1B) . To examine whether genotoxic stress was influenced by DYRK2 knockdown, we performed alkaline comet assay. The result indicated that the treatment with ADR in DYRK2 knockdown cells increased the extent of percentage of damaged DNA in tail compared to control cells (Fig. S2) . Given that DYRK2 is a Ser/Thr kinase, we examined the requirement of DYRK2 kinase activity in the monoubiquitination activity of RNF8 using the DYRK2 inhibitor, Harmine. An in vitro kinase assay was performed to evaluate the inhibition of DYRK2 activity by Harmine (Fig. S3) . As shown MDM2  RNF8  TRAF7  TRIM21  RNF25  RNF19A  NOSIP  RNF43  RNF168  TRIM9  MEX3B  RNF38  RAD18  RNF4  LINCR  RNF32  PJA1  BIRC3  MIB2 3 . DYRK2 contributes to 53BP1 foci formation under genotoxic stress, leading to DNA repair. (A) Cells of the human osteosarcoma cell line U2OS were transfected with control siRNA or dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) siRNA and then treated with Adriamycin (ADR) for 4 h. Cells were stained with anti-53BP1. The nuclei were stained with DAPI. The quantification of cells with more than five 53BP1 foci was performed from three fields in two independent experiments. Statistical analysis was performed with the Student's t-test, and P < 0.05 was defined as statistically significant (mean AE SD; n = 6). Scale bar; 10 lm. (B) U2OS cells were treated with irradiation for 1 h. Cells were stained with anti-DYRK2 and anti-c-H2AX. The nuclei were stained with DAPI. Scale bar; 10 lm.
previously [10] , DYRK2 strongly phosphorylated p53 at Ser46. In contrast, Harmine effectively inhibited the p53 phosphorylation by DYRK2, confirming its inhibitory effect on DYRK2 (Fig. S3) . In our previous study, we demonstrated the phosphorylation of p53 at Ser46 by DYRK2 in response to DNA damage [10] . To examine whether Harmine suppresses Ser46 phosphorylation in cells, U2OS cells were treated with ADR in the presence or absence of Harmine. DNA damage-induced Ser46 phosphorylation was attenuated by Harmine treatment (Fig. S3) . To assess if Harmine inhibited damage-induced c-H2AX monoubiquitination, U2OS cells were treated with Harmine, followed by stimulation with ADR (Fig. 2C) . DNA damageinduced c-H2AX monoubiquitination was remarkably inhibited by Harmine treatment (Fig. 2C) . These results indicated the requirement of DYRK2 kinase activity for the RNF8-mediated monoubiquitination of c-H2AX. The U2OS cell carrying the DR-GFP was transfected with control siRNA or DYRK2 siRNA, and then transfected with I-SceI plasmid. Statistical analysis was performed using the Student's t-test, and P < 0.01 was defined as statistically significant (mean AE SD; n = 5). The percentage of GFP-positive cells: control siRNA 2.54%, DYRK2 siRNA 1.40%.
including 53BP1, to the DNA damage sites. To verify the function of DYRK2 in DNA repair, we examined its requirement in the 53BP1 foci formation in response to genotoxic stress (Fig. 3A) . 53BP1 formation, observed in ADR-treated U2OS cells, was markedly declined in DYRK2-depleted cells (Fig. 3A) . To further investigate the function of DYRK2 on DNA repair, we examined the colocalization of endogenous DYRK2 and c-H2AX under genotoxic stress. Interestingly, DYRK2 and c-H2AX colocalized in the nucleus and exhibited foci-like distribution following DNA damage, suggesting their potential function at the DSB sites (Fig. 3B ).
DYRK2 and RNF8 are colocalized in the nucleus under genotoxic stress for DNA repair
To investigate the involvement of DYRK2 along with RNF8 in the repair of DSBs, mCherry-tagged RNF8 C403S mutant, and GFP-tagged DYRK2 K178R mutant were colocalized in cells. RNF8 C403S mutant, a catalytically inactive mutant was used [5] to avoid induction of excessive ubiquitination by overexpressing active RNF8 [27] , and DYRK2 K178R , the kinase dead mutant was used to avoid induction of apoptosis by overexpressing active DYRK2 [10] . Under unstressed conditions, mCherry-tagged RNF8 C403S mutant was localized in the nucleus, and GFP-tagged DYRK2 K178R mutant was localized in the cytoplasm. Notably, both mCherry-tagged RNF8 C403S mutant and GFP-tagged DYRK2 K178R mutant were colocalized in the nucleus in response to DNA damage (Fig. 4A) . These results suggest the cooperation of RNF8 with DYRK2 in the repair of DSBs. To examine this possibility, we performed an HR assay based on the I-SceI system [28] . Compared to control siRNA-transfected cells, depletion of DYRK2 failed to repair the DNA damage, which was triggered by I-SceI (Fig. 4B) . To determine if cell cycle distributions were influenced in these experimental settings, we performed cell cycle analysis. The result demonstrated that there was little if any difference between control and DYRK2 siRNA-transfected cells (Fig. S4) . These findings strengthen the evidence indicating the involvement of DYRK2 in the regulation of DSB repair.
Discussion
Post-translational modification, including phosphorylation and ubiquitination, initiates a quick response to DNA damage. Specifically, monoubiquitination of histone H2AX contributes to the recruitment of DNA repair factors at the DSBs. Besides histone ubiquitination, Fanconi anemia complementation group D2 (FANCD2) monoubiquitination promotes the assembly of FANCD2 and BRCA2/FANCD1 at DSB sites [29] . Furthermore, FANCI is ubiquitinated and evokes DNA repair along with FANCD2 [13] . These findings suggest that monoubiquitination promotes the assembly of checkpoint and repair factors at DSB sites. In the present study, we elucidated the involvement of DYRK2 in DNA repair at the DSB sites. We previously proved the activation of ATM within an hour in response to genotoxic stress and its subsequent attenuation suddenly at 4 h [25] . Corresponding to the activation of ATM, monoubiquitination of c-H2AX by RNF8 was seen in the early stages of DNA damage ( Fig. 2A) , suggesting the dependence of RNF8 ubiquitination on ATM activation. Because ATM activates DYRK2 in response to DNA damage [25] , the kinetics of ATM, DYRK2, and RNF8 activity possibly occurs simultaneously. In this study, we performed high-throughput screening based on wheat germ cell-free system and identified RNF8 as a binding partner for DYRK2 (Fig. 1A) . RNF8 is well known for its role in DNA repair [30] , however, its interaction with DYRK2 and their mechanism of action remains unknown. The present study demonstrates the interaction of DYRK2 and its colocalization with RNF8 under genotoxic-stressed conditions ( Figs 1B and 4A ), suggesting the cooperation between the two in repairing DSBs (Fig. 5A,B) . In addition, the HR assay indicated reduced repair efficiency associated with the depletion of DYRK2 (Fig. 4B) .
Results from our previous studies have proved the involvement of DYRK2 in the induction of apoptosis and in the inhibition of EMT [9, 10] . In this context, we identified a novel function of DYRK2 in the DNA repair pathway, aside from its tumor-suppressive functions. Considering that DYRK2 is a kinase, it is expected to phosphorylate RNF8 in cells, whereas we could not detect DYRK2-mediated phosphorylation of RNF8. Further studies are required for clarifying the mechanism involved in the cooperation of DYRK2 and RNF8 in the DNA repair process for better understanding their role in cancer biology. 
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